Search Results
Search this site
23 results found with an empty search
- Why arterial tissue has to be tested in two directions at once
A uniaxial tensile test gives a clean curve, a reproducible number and a good fit. Applied to a blood vessel, it can also give a material model that is confidently wrong. The reason has less to do with the quality of the measurement than with what a single loading direction is able to reveal. An artery is never loaded in one direction In a pressurised vessel the wall carries load along two axes at once. For a thin walled cylinder the circumferential stress is roughly twice the axial stress, and both are present in every cardiac cycle. The vessel is also stretched axially in situ, so even at rest the tissue is not in the unloaded state it occupies on a bench. The wall is not a homogeneous rubber either. It is a layered composite in which collagen fibres run in preferred orientations, embedded in elastin, smooth muscle and ground substance. Stiffness therefore depends on the direction of loading, and the dependence is strong. A uniaxial test samples one path through that behaviour: the curve is true for that strip, in that direction, but it cannot show how the tissue responds when both directions are loaded together, because the transverse direction stays free to contract throughout. The difficulty is identifiability, not accuracy Constitutive models for arterial tissue typically carry parameters for matrix stiffness, fibre stiffness, fibre non-linearity, mean fibre orientation and fibre dispersion. Several different combinations of those parameters reproduce a single uniaxial curve to within experimental scatter. The fit looks excellent. The parameters are nonetheless not uniquely determined. That becomes visible as soon as the model is asked to do anything beyond reproducing the test it was fitted to. Parameter sets that agree on the uniaxial response can disagree substantially once the same tissue is pressurised or loaded at a different ratio between the axes. The model has not failed. It was never constrained enough to be identified. Biaxial testing constrains it. Loading two perpendicular axes at several different ratios requires a single parameter set to reproduce several independent responses at once. Fibre orientation in particular becomes identifiable, because orientation determines how load is shared between the axes, and that sharing changes measurably when the ratio changes. A model fitted this way is not automatically correct, but it has been asked a harder question. What the test actually is The device loads a sample along two perpendicular axes by imposing force or displacement in each. Four motors and four load cells are controlled independently, so the axes can be driven at different ratios and each can run in force or displacement control. Samples are square or cruciform, mounted using rakes, sutures or clamps depending on the tissue. The hard part is holding the tissue Loading a soft tissue sample is straightforward. Holding it without changing what is being measured is not. A clamp grips the full width of the sample edge, so when the perpendicular axis is loaded that edge cannot contract laterally. The boundary condition, rather than the material, then governs much of the strain field, and the centre of the sample deforms partly in response to how it was held. Rakes avoid most of this. Samples are mounted on sets of parallel needles roughly a millimetre apart, and because the needles are discrete rather than continuous, the tissue between them keeps its freedom to move laterally and deforms more nearly as the wall does in situ. This reduces the problem without removing it, since tissue immediately around each needle is still locally distorted. Which is why strain is not taken from the actuators at all. Measuring the specimen, not the machine A speckle pattern is applied to the sample surface and tracked optically through the test. The displacement field is reconstructed from how that pattern moves, and only the central portion of the area enclosed by the rakes is used for analysis. Everything near the needles is discarded. Two further artefacts are worth naming, because both are easy to miss and hard to detect afterwards. A sample that bows slightly out of plane produces apparent in plane strains that were never there. And soft tissue is not stress free when it is mounted, so treating the mounted state as the zero strain state introduces a systematic offset. Both are addressable, but only if they are measured rather than assumed. The conditions around the test Samples are held in phosphate buffered saline at 37 degrees Celsius, because the response of soft tissue depends on temperature and hydration. Preconditioning cycles precede the recorded cycle, because the first cycles of a biological tissue are not repeatable. None of this is glamorous, and all of it determines whether the parameters mean anything outside the laboratory that produced them. From curves to a model that can be trusted Fitting a constitutive model to biaxial data is the beginning rather than the end. The stronger step is to require the fitted model to reproduce a loading state that was not used in the fit: inflation of the intact vessel, or the in vivo pressure diameter behaviour measured by imaging in the same subject. The model is then required to describe the tissue as it behaves in the body, not only as it behaves clamped in a rig. This is the direction regulatory expectations are moving as well. Credibility frameworks for computational modelling in medical devices, including ASME V&V 40, place the weight of the argument on validation evidence, and validation evidence is an experiment. Questions worth settling before tissue is cut How will the sample be held, and what does that boundary condition do to the strain field? How will strain be measured, and over what region? How many load ratios will be run, and is that enough to identify the parameters of the model you intend to fit? And against what independent loading state will the fitted model be validated? A laboratory that has thought about these will answer quickly and is usually pleased to be asked, because they are the questions that separate a characterisation study from a set of curves.
- Biomechanical testing for medical device design
In medical device development, understanding the biomechanics of biological tissues is essential to ensure that the final product functions safely and effectively. Biomechanics involves the study of the mechanical properties of tissues like bones, tendons, ligaments, and muscles. Proper testing and analysis of these tissues, along with the materials used in medical devices, are crucial for creating devices that can withstand the stresses placed on them in the human body. The role of biomechanics in medical device design Biomechanics bridges engineering principles with biological systems. For medical devices, this means understanding the mechanical properties of the tissue a device is designed to replace or interact with. For example, if a device is intended to replace a bone, knowing the bone's mechanical properties is vital for predicting how the device will perform in real-world conditions. Testing biological tissues under various loading conditions allows engineers to design medical devices that are both functional and durable. Bone structure and properties Bone is a complex composite material made up of both solid and fluid phases. The solid phase provides structural integrity, while the fluid phase, primarily water, helps in maintaining flexibility and resilience. Bone tissues can be categorized into cortical (compact) bone and cancellous (spongy) bone, each exhibiting distinct mechanical properties. Cortical bone is dense and forms the outer layer of bones. It has a higher Modulus of Elasticity, which helps it resist bending and twisting forces. Cancellous bone, in contrast, is more porous and less dense, providing the ability to absorb and store energy. The varying structures of cortical and cancellous bones affect their response to mechanical loads such as compression, tension, and shear. Understanding the mechanical behavior of bone Bones exhibit different mechanical behaviors depending on factors like age, sex, and health. Additionally, the direction of applied force influences the bone's response. The stress-strain curve is often used to assess how bones react to applied forces. Initially, bone behaves elastically, meaning it returns to its original shape once the load is removed. However, once the yield point is surpassed, bones begin to undergo plastic deformation, which can lead to fracture. Testing bone materials also involves understanding time-dependent behavior such as creep and stress relaxation. Creep refers to the slow elongation of a material under a constant load, while stress relaxation measures the decrease in stress when a material is held at a constant strain. Key biomechanical tests for medical devices Several tests are employed to evaluate the biomechanical properties of both biological tissues and medical devices: Creep and recovery tests: These tests involve applying a constant load to a material for a set period and then removing it to observe how the material recovers. This is important for understanding the long-term behavior of medical implants under sustained stress. Stress relaxation tests: Here, a material is strained to a specific point, and the stress response is measured while the strain remains constant. This test helps in understanding how materials behave when they are stretched and held in place. Dynamic testing: This involves applying oscillatory forces to the material to measure its strain response. Dynamic tests help assess the material's ability to withstand varying forces over time, simulating real-life conditions. In addition to these tests, the phenomenon of hysteresis — where the loading and unloading curves differ due to energy loss (often through friction) — can also be examined during dynamic mechanical testing. Material considerations for medical devices The choice of materials used in medical devices depends on their mechanical properties, such as Elastic Modulus, yield strength, and elongation to failure. Different materials are chosen for specific applications: Metals and alloys: These materials are often used in load-bearing devices, such as hip and knee implants, because they have high strength and durability. However, metals may require surface treatments to prevent adverse reactions with surrounding tissues. Ceramics: Known for their excellent compressive strength, ceramics are commonly used in dental implants. However, their poor tensile properties limit their use in applications requiring flexibility or resistance to bending forces. Polymers: These materials offer flexibility in terms of shape and controlled degradation rates, making them suitable for a range of applications. Polymers, however, may experience wear and fatigue under repeated loading, and careful selection is needed to ensure they meet the necessary biomechanical requirements. Standards and regulations for biomechanical testing In the EU, medical device testing adheres to rigorous standards set by regulatory bodies to ensure safety and performance. Manufacturers must ensure that their devices meet specific biomechanical criteria based on the intended use. This includes conducting extensive mechanical testing to demonstrate that the device can withstand the forces it will encounter in the body. Predefined ISO standards outline testing requirements for materials used in medical devices, including tests for mechanical properties, biocompatibility, and long-term durability. By following these standards, manufacturers can ensure their devices are safe, effective, and ready for clinical use. Conclusion Biomechanical testing is a critical part of medical device development, ensuring that implants and other devices can mimic the properties of natural tissues and withstand the stresses they will encounter in the human body. With advancements in testing methodologies and material science, designers can develop devices that provide better outcomes for patients while meeting stringent regulatory standards in the EU. Interested how FIBER LABS can help? Contact us!
- Why two good laboratories measuring the same tissue get different numbers
A material parameter looks like a fact. It arrives in a report as a number with a unit, it goes into a design file or a finite element model, and from that point onward it behaves like something that was measured rather than something that was produced. For engineered materials that is close enough to true. For biological tissue it is not, and the gap is larger than most people outside a test lab would guess. What "produced" means Between a piece of tissue and a number on a page sit perhaps twenty decisions. How the tissue was stored, and for how long. Whether it was frozen, and how it was thawed. How it was kept hydrated during preparation and during the test. How the specimen was cut, and with what. How its thickness was measured - and thickness enters the stress calculation directly, so an error there propagates straight through. How it was gripped, and whether it slipped. How many preconditioning cycles came before the recorded data. What strain rate was used. Whether strain was taken from the crosshead or measured optically on the specimen itself. And finally which constitutive model was fitted, with which optimiser, over which part of the curve. Each of those decisions is defensible. Each is made differently in different laboratories, usually for good reasons. And almost none of them travel with the number. The experiment nobody had run C4Bio, the Community Challenge towards Consensus on Characterization of Biological Tissue, was set up to find out how much that matters. It was initiated by FIBER LABS, the Virtual Physiological Human Institute, and the Avicenna Allience. The design is deliberately plain. Take one well-defined use case, uniaxial tensile testing of porcine aorta. Prepare samples from a common source. Send them to expert laboratories around the world. Ask each to report the mechanical behaviour of the tissue. In the first round, 24 laboratories were invited to apply whatever method they normally used. The results showed substantial methodological diversity, and substantial variability in the resulting stress–stretch behaviour. That much might have been predicted. What happened when everybody agreed The second round is the interesting one. The participating laboratories developed a consensus protocol together, and 19 adopted it. Sample preparation was standardised. A common cutting tool was distributed so that specimen geometry would be consistent. Thickness measurement was harmonised. The test protocol itself was fixed. Significant variability persisted. And it could not be attributed solely to biological differences between the samples. Something about how the measurement is performed (beyond every step that had just been standardised) is still moving the answer. That is an uncomfortable result to publish, and it is the most useful thing in the paper. It says that harmonising the obvious variables is necessary but not sufficient, and it points the community at the harder question of which of the remaining ones actually matter. Why this should concern an engineer If you buy tissue data, or generate it in-house, the spread between competent laboratories is a real uncertainty in your design input - and it is normally invisible, because the number arrives without its provenance. If you build computational models it is more pointed. Model credibility frameworks (ASME V&V 40, and recent regulatory guidance on computational modelling in device submissions) ask you to justify the evidence your model rests on. The uncertainty in the validation data is part of that case. "We took the value from the literature" is a weak position if the literature values for that tissue span a wide range and none of them carry their protocol. And if you benchmark a device against published data, you may be comparing yourself against a protocol as much as against a material. Five questions worth asking your test laboratory How was the specimen prepared and stored, and is the protocol written down? How was thickness measured, given that it enters the stress calculation directly? How many preconditioning cycles were applied, and does the reported data come from before or after them? Was strain measured on the specimen or taken from the machine? And which constitutive model was fitted, over what part of the curve, and how good was the fit? None of these is an accusation. Any laboratory worth using will answer them quickly and will be pleased to be asked. A laboratory that cannot is telling you something. Round three The third round is now open, and it introduces something new: synthetic samples developed specifically to mimic the mechanical behaviour of arterial tissue. The reasoning is simple. If biological variability is removed from the specimen, then whatever spread remains between laboratories has to come from the measurement itself. It is the sharpest lens the challenge has had. One last thing FIBER LABS coordinates C4Bio. We are also a testing laboratory, which means every one of these findings applies to us as much as to anyone who took part. That is uncomfortable, and it is precisely why the work is worth doing. The alternative is a field in which every laboratory quietly assumes its own numbers are the right ones. Read the full publication here: https://pubmed.ncbi.nlm.nih.gov/41138606/
- Ensuring Medtech Regulatory Compliance Made Simple with Medtech Compliance Testing Solutions
Navigating the complex world of medical technology regulations can feel overwhelming. You develop innovative devices or tissue engineering solutions, but ensuring they meet all regulatory requirements is crucial. Without compliance, your product cannot reach the market or help patients. The good news is that with the right approach and tools, you can simplify this process. This article guides you through practical steps to ensure medtech regulatory compliance efficiently and confidently. Understanding Medtech Compliance Testing Solutions Medtech compliance testing solutions are designed to help you verify that your medical devices or tissue-engineered products meet the necessary standards. These solutions cover a wide range of tests, from safety and performance to biocompatibility and durability. By using these services, you reduce risks and speed up your product’s path to market. Why choose medtech compliance testing solutions? They provide expert knowledge of current regulations. They offer precise and reliable testing methods. They help identify potential issues early. They support documentation needed for regulatory submissions. For example, if you develop a new implant, compliance testing will check if the materials used are safe for the human body and if the device performs as intended under various conditions. This reduces the chance of costly recalls or delays. Close-up view of a laboratory technician conducting medical device testing Key Steps to Simplify Regulatory Compliance You can break down the compliance process into clear, manageable steps. Follow these to stay on track: 1. Know the Regulations That Apply Start by identifying which regulations affect your product. Different countries and regions have specific rules. For example, in Europe, the Medical Device Regulation (MDR) applies, while in the US, the FDA oversees medical devices. Understanding these rules helps you plan your testing and documentation. 2. Develop a Compliance Strategy Early Involve compliance experts from the beginning of your product development. This ensures that design choices align with regulatory requirements. Create a roadmap that includes all necessary tests, timelines, and documentation. 3. Use Accredited Testing Facilities Choose testing labs with recognized accreditation. Accredited labs follow strict quality standards, ensuring your test results are valid and accepted by regulators. This saves time and builds trust in your product. 4. Document Everything Thoroughly Keep detailed records of all tests, results, and procedures. Proper documentation is essential for regulatory submissions and audits. Use clear, organized formats to make information easy to review. 5. Stay Updated on Regulatory Changes Regulations evolve. Subscribe to updates from regulatory bodies and industry groups. Adjust your compliance strategy as needed to stay current. How to Implement Medtech Compliance Testing Solutions Effectively Implementing testing solutions requires careful planning and execution. Here are actionable recommendations: Select the right tests for your product type. For example, biocompatibility tests are critical for implants, while electrical safety tests matter for electronic devices. Schedule tests early in development. Early testing helps catch issues before they become costly problems. Collaborate closely with testing providers. Share your product details and intended use to get tailored advice. Review test reports carefully. Understand any failures or warnings and address them promptly. Integrate testing results into your quality management system. This supports continuous improvement and compliance. By following these steps, you ensure your product meets all necessary standards without unnecessary delays. Eye-level view of a medical device undergoing compliance testing in a lab The Role of medtech regulatory compliance testing in Product Success Medtech regulatory compliance testing is not just a hurdle; it is a vital part of your product’s success. It provides: Confidence in safety and performance. You know your product works as intended and is safe for patients. Market access. Compliance opens doors to sell your product in regulated markets. Risk reduction. Identifying and fixing issues early prevents costly recalls or legal problems. Improved reputation. Demonstrating compliance builds trust with healthcare providers and patients. For example, a tissue-engineered skin substitute must pass biocompatibility and sterility tests before it can be used clinically. These tests ensure the product does not cause adverse reactions and is safe for patient use. Best Practices for Ongoing Compliance and Quality Compliance is not a one-time task. Maintain it throughout your product’s lifecycle by: Regularly reviewing product performance and safety data. Updating documentation with any changes or improvements. Conducting periodic audits of your quality management system. Training your team on regulatory requirements and updates. Engaging with regulatory consultants or experts when needed. This proactive approach helps you stay ahead of regulatory demands and maintain high product standards. Moving Forward with Confidence You have the tools and knowledge to simplify medtech regulatory compliance. By leveraging medtech compliance testing solutions, you reduce risks and accelerate your product’s journey from development to market. Focus on clear planning, thorough testing, and detailed documentation. Stay informed and adapt to changes. This approach ensures your medical technology meets the highest standards and delivers real benefits to patients. Take the next step today - integrate compliance testing into your development process and secure your product’s future success.
- 𝐖𝐡𝐞𝐧 “𝐝𝐢𝐠𝐢𝐭𝐚𝐥” 𝐦𝐞𝐚𝐧𝐭 𝐮𝐬𝐢𝐧𝐠 𝐲𝐨𝐮𝐫 𝒅𝒊𝒈𝒊𝒕 𝐟𝐢𝐧𝐠𝐞𝐫: 100 𝐲𝐞𝐚𝐫𝐬 𝐨𝐟 𝐛𝐢𝐨𝐦𝐞𝐜𝐡𝐚𝐧𝐢𝐜𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐡𝐞𝐚𝐫𝐭
100 years ago, in 1925, surgeon 𝐇. 𝐒. 𝐒𝐨𝐮𝐭𝐭𝐚𝐫 published a remarkable paper titled “𝘛𝘩𝘦 𝘚𝘶𝘳𝘨𝘪𝘤𝘢𝘭 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘰𝘧 𝘔𝘪𝘵𝘳𝘢𝘭 𝘚𝘵𝘦𝘯𝘰𝘴𝘪𝘴.” At a time when surgeons barely dared to touch the heart, Souttar quite literally did just that. What’s striking is not only the bravery of the procedure, but the way the heart was already being understood as a 𝐦𝐞𝐜𝐡𝐚𝐧𝐢𝐜𝐚𝐥 𝐬𝐲𝐬𝐭𝐞𝐦. Long before imaging, pressure catheters, or computational models, Souttar described how the mechanics of stenosis and regurgitation could be 𝐟𝐞𝐥𝐭. By inserting a finger into the beating heart through the auricular appendage, he gained insights no murmur or auscultation could provide. When his finger briefly blocked the stenosed mitral orifice, blood pressure fell to zero: a direct, visceral demonstration of flow obstruction. That moment made something clear to him: “𝘛𝘰 𝘩𝘦𝘢𝘳 𝘢 𝘮𝘶𝘳𝘮𝘶𝘳 𝘪𝘴 𝘢 𝘷𝘦𝘳𝘺 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘵 𝘮𝘢𝘵𝘵𝘦𝘳 𝘧𝘳𝘰𝘮 𝘧𝘦𝘦𝘭𝘪𝘯𝘨 𝘵𝘩𝘦 𝘣𝘭𝘰𝘰𝘥 𝘪𝘵𝘴𝘦𝘭𝘧 𝘱𝘰𝘶𝘳𝘪𝘯𝘨 𝘣𝘢𝘤𝘬 𝘰𝘷𝘦𝘳 𝘰𝘯𝘦’𝘴 𝘧𝘪𝘯𝘨𝘦𝘳.” This was “digital” biomechanics, long before the term meant sensors, data, or simulations. Just a surgeon, a beating heart, and a profound realization: 𝐜𝐚𝐫𝐝𝐢𝐚𝐜 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐢𝐬 𝐦𝐞𝐜𝐡𝐚𝐧𝐢𝐜𝐚𝐥 𝐚𝐭 𝐢𝐭𝐬 𝐜𝐨𝐫𝐞. Today, at FIBER LABS , we no longer need to put a finger inside the heart to understand it, but the principle is exactly the same. We study 𝐟𝐨𝐫𝐜𝐞𝐬, 𝐟𝐥𝐨𝐰𝐬, 𝐝𝐞𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧𝐬, 𝐚𝐧𝐝 𝐦𝐚𝐭𝐞𝐫𝐢𝐚𝐥 𝐛𝐞𝐡𝐚𝐯𝐢𝐨𝐫 to uncover how cardiovascular structures function, fail, and respond to treatment. From tactile intuition to advanced cardiovascular biomechanical testing, the journey spans 100 years and it continues to shape the future of cardiovascular research at FIBER LABS . With thanks to Dr. Tom Treasure for highlighting this; more fascinating insights can be found in his book The Heart Club.
- Biomechanical characterization of the human pia-arachnoid complex using bulge inflation testing and the virtual fields method
Published in Acta Biomaterialia (1 October 2025) Paulien Vandemaele, Heleen Fehervary , Lauranne Maes , Bart Depreitere , Jos Vander Sloten , Nele Famaey Abstract The cranial meninges are crucial structures in protecting the brain against injury. Hence, a biofidelic mechanical representation of these tissues is essential for accurate computational predictions of stress and strain in the brain during a traumatic brain injury. This study presents a biomechanical analysis of human pia-arachnoid complex tissue, which is formed by the two innermost meningeal layers. Bulge inflation experiments were performed on 29 pia-arachnoid complex samples to investigate their in-plane mechanical properties and parameters of the modified one-term Ogden model were derived with the virtual fields method. Due to its anatomical structure, pia-arachnoid complex tissue has an inhomogeneous thickness with a median value of 0.400mm. A bivariate normal probability density function was identified for the log-transformed parameters obtained from different specimens and samples with mean values 0.30MPa and alpha=36.97. Results show that the mechanical behavior of pia-arachnoid complex tissue is highly nonlinear in contrast to the linear elastic models often implemented in state-of-the-art finite element head models. Since the pia-arachnoid complex tissue is closely wrapped around the brain, it is important to include a more realistic mechanical behavior into these models. Paulien Vandemaele, Heleen Fehervary, Lauranne Maes, Bart Depreitere, Jos Vander Sloten, Nele Famaey, Biomechanical characterization of the human pia-arachnoid complex using bulge inflation testing and the virtual fields method , Acta Biomaterialia , 2025,ISSN 1742-7061, https://doi.org/10.1016/j.actbio.2025.09.035 .
- Course on Image-based Mechanics: an Overview of Experimental and Numerical Approaches.
Join us in Udine, Italy, for an advanced hands-on course hosted by CISM – International Centre for Mechanical Sciences : Image-based Mechanics: an Overview of Experimental and Numerical Approaches . 🎓 As part of this collective course organized by Julien Réthoré and José Xavier , FIBER LABS’ Director Nele Famaey will contribute with six in-depth lectures on: Characterization & parameter fitting of uniaxial, biaxial, compression and bulge inflation experiments Image-based geometry & deformation analysis, including digital image correlation and the virtual fields method Micro-CT based multiscale modelling You’ll gain insights into the latest experimental and numerical techniques in image-based mechanics and learn practical strategies to improve your own research and applications. 📅 Deadline to register: September 23, 2025 🔗 Register here: https://cism.it/en/activities/courses/C2516/ Don’t miss this opportunity to learn from leading experts and connect with peers in the field of (bio)mechanical sciences!
- FIBER LABS 4 Kids
Last week, we had the absolute pleasure of welcoming some of our youngest and most curious future researchers to the FIBER LABS! Together with our lab experts, they rolled up their sleeves to investigate how to fix Filiberke's broken leg. With wide eyes, little hands, and big imaginations, they explored the wonders of biomechanics in action. The laughter, questions, and excitement in the room left no doubt—thanks to these budding scientists, the future of biomechanics is brighter than ever!
- Meet FIBER LABS at MedTech MeetUp 2024, on March 14th in Brussels.
Stop by our booth and take a moment to discuss with us our expertise in biomechanical testing of biomaterials and medical devices.
- FIBER LABS Presented at ESB 2024
Heleen Fehervary , Research Manager at FIBER LABS, recently presented our comprehensive services and special access program for academic researchers to the ESB community ( ESB Congress ).
- FIBER LABS celebrates 600 years KU Leuven: Exploring the Human Body through Engineering
Join us at the KU Leuven Core Facility for Biomechanical Experiments as part of the celebration of 600 years of innovation and discovery! Embark on a fascinating journey through the human body with us. Discover how mechanical stress plays a pivotal role in various diseases, such as osteoporosis, osteoarthritis, arterial ruptures, and certain neurodegenerative conditions. Explore how we use different types of mechanical tests to map out the properties of biological tissues like bone, cartilage, blood vessels, and brain tissue. Learn how this vital information helps us better understand disease processes and develop improved prosthetic materials. On Saturday the 15th of February and Sunday the 16th of February, we will demonstrate how these tissue properties are used to create virtual patient models, enabling new prosthetics or interventions to be tested first "in silico" (i.e., on the computer) before any real-world trials on animals or patients. Come see how science and engineering come together to transform healthcare at this special event!
- FIBER LABS opens its doors for KU Leuven’s 600-year celebration
This past weekend, FIBER LABS proudly took part in KU Leuven’s 600-year anniversary celebrations by hosting a two-day open lab tour. Visitors of all ages had the chance to explore the fascinating world of biomechanics, uncovering the science behind movement, bone strength, and medical implants. From observing joint motion to testing the mechanical properties of bone and implants, guests got a hands-on experience of the cutting-edge research that shapes modern healthcare. They explored the intricate microstructure of bone, learned how blood flows through the body, and discovered what happens when things go wrong—and how science can help. We want to extend a heartfelt thank you to everyone who visited our lab, bringing curiosity and enthusiasm. This curiosity has been a driving force throughout KU Leuven’s 600-year history, and we are proud to continue that tradition into the future.











